|
Elucidating the Function of the NF1 Tumor Suppressor and its Effector Pathways in
|
5R01CA111754-09
|
$267,627
|
$133,814
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mechanisms of bHLH Mediated Lineage Specification
|
5K08CA169014-02
|
$158,909
|
$79,455
|
Fong, Abraham
|
FRED HUTCHINSON CAN RES CTR
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-09
|
$311,292
|
$311,292
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-39S1
|
$31,250
|
$313
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-39
|
$5,345,058
|
$53,451
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Understanding the epigenetic basis of human familial paraganglioma
|
1F31CA180698-01
|
$40,932
|
$40,932
|
Her, Yeng
|
MAYO CLINIC ROCHESTER
|
|
Molecular Basis of Familial Paraganglioma
|
1R01CA166025-01A1
|
$296,933
|
$296,933
|
MAHER, LOUIS
|
MAYO CLINIC ROCHESTER
|
|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$400,740
|
N/A
|
National Cancer Institute
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$175,183
|
$175,183
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$700,734
|
$700,734
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$128,818
|
$25,764
|
Bates, Susan
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$224,699
|
$112,349
|
Beutler, John
|
CCR (NCI)
|
|
Studies of Histone Functions in Chromatin; H2AX and DNA DSBs
|
ZIA BC 006140
|
$869,173
|
$43,459
|
Bonner, William
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$253,796
|
$76,139
|
Buck, Christopher
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$495,263
|
$346,684
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$742,894
|
$594,315
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$4,763,869
|
$762,219
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
|
ZIA BC 010026
|
$274,890
|
$54,978
|
Colburn, Nancy
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$482,268
|
$96,454
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$482,268
|
$168,794
|
Daar, Ira
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$536,933
|
$53,693
|
Dean, Michael
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$485,878
|
$24,294
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 010839
|
$232,277
|
$232,277
|
Fine, Howard
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
|
ZIA BC 011101
|
$270,990
|
$270,990
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Animal Therapeutics Core
|
ZIC BC 011086
|
$464,554
|
$464,554
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,903,460
|
$2,903,460
|
Fine, Howard
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$630,367
|
$126,073
|
Gottesman, Michael
|
CCR (NCI)
|
|
Molecularly targeted natural products discovery from diverse natural sources
|
ZIA BC 011467
|
$659,534
|
$131,907
|
Gustafson, Kirk
|
CCR (NCI)
|
|
Sensitization of chordoma cell lines to ionizing radiation
|
ZIA BC 011326
|
$56,706
|
$5,671
|
Haglund, Karl
|
CCR (NCI)
|
|
RGB-286638 as a radiation sensitizer
|
ZIA BC 011454
|
$170,118
|
$42,530
|
Haglund, Karl
|
CCR (NCI)
|
|
Role of Selenium in Development and Health
|
ZIA BC 005317
|
$380,000
|
$57,000
|
Hatfield, Dolph
|
CCR (NCI)
|
|
Development and use of nanoFACS for analysis and sorting of nanoparticles
|
ZIA BC 011502
|
$49,047
|
$2,452
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$336,277
|
$63,893
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$336,277
|
$67,255
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
|
ZIA BC 010795
|
$389,427
|
$194,714
|
Kashlev, Mikhail
|
CCR (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
ZIA BC 010592
|
$69,495
|
$55,596
|
Khan, Javed
|
CCR (NCI)
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$347,473
|
$347,473
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$949,760
|
$427,392
|
Khan, Javed
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$115,824
|
$46,330
|
Khan, Javed
|
CCR (NCI)
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIA BC 011002
|
$92,660
|
$92,660
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$231,649
|
$115,824
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$404,584
|
$44,504
|
Kleiner, David
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,011,636
|
$151,745
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Evaluation of the Natural History of Patients withTumors of the Central Nervous
|
ZIA BC 011482
|
$162,452
|
$162,452
|
Kreisl, Teri
|
CCR (NCI)
|
|
Develop novel therapeutics for patients with treatment resistant glioma
|
ZIA BC 011484
|
$162,452
|
$162,452
|
Kreisl, Teri
|
CCR (NCI)
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$256,398
|
$256,398
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Regulation of T-bet expression in TH17 cells by microRNAs
|
ZIA BC 011432
|
$256,398
|
$256,398
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$626,490
|
$31,324
|
Linehan, W. Marston
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $27,148,695
|